C4 Therapeutics, Inc. ($CCCC)
Filing Information
| Accession Number | 0001470831-26-000176 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 13, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
287,529
Total Value
$31,334.31
P&L
+inf% (+$648,000.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Feb 13, 2026 | Grant/Award | 240,000 | $0.00 | $0.00 | 396,382 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 14, 2026 | Exercise/Conversion | 30,950 | $0.00 | $0.00 | 396,382 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 14, 2026 | Tax Withholding | 16,579 | $1.89 | $31,334.31 | 379,803 | Direct | โ | View Details |